Skip to main content
Premium Trial:

Request an Annual Quote

GE to Launch New CodeLink Assay Within Two Weeks

TORONTO, Oct. 30 (GenomeWeb News) - GE Healthcare will launch its overdue 16-chamber rat ADME assay for the CodeLink platform by the middle of November, Lisa D'Anzi, marketing director for the platform, said yesterday at the American Society of Human Genetics 54th annual meeting.

 

"The assay will launch toward the end of next week or the beginning of the following," pending the completion of last-minute data, said D'Anzi. She made the remarks following a GE Healthcare-sponsored CodeLink workshop that occurred here yesterday during the ASHG meeting, held here last week.

 

BioArray News, GenomeWeb News' sister publication, reported in early June that the company originally intended to introduce the ADME-Rat 16 assay within 60 to 90 days - that is, before September.

 

The assay was to be the first produced for the CodeLink platform after GE Healthcare acquired Amersham in April. Instead, the whole mouse genome assay, which launches next week, will become the platform's first. D'Anzi said GE Healthcare was "already selling" whole mouse genome assays.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.